145 related articles for article (PubMed ID: 17992461)
1. Dermatomyositis: an association of gingival telangiectases and anti Jo-1 antibody in the adult.
Dourmishev LA; Dourmishev AL; Schwartz RA
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Jun; 16(2):67-72. PubMed ID: 17992461
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of autoantibody screening in patients with autoimmune myositis.
Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
[TBL] [Abstract][Full Text] [Related]
3. Oral manifestations as important symptoms for juvenile dermatomyositis early diagnosis: a case report.
Gonçalves LM; Bezerra-Júnior JR; Gordón-Núñez MA; Libério SA; de Fátima Vasconcelos Pereira A; da Cruz MC
Int J Paediatr Dent; 2011 Jan; 21(1):77-80. PubMed ID: 20659183
[TBL] [Abstract][Full Text] [Related]
4. Gingival telangiectases: an underappreciated physical sign of juvenile dermatomyositis.
Ghali FE; Stein LD; Fine JD; Burkes EJ; McCauliffe DP
Arch Dermatol; 1999 Nov; 135(11):1370-4. PubMed ID: 10566836
[TBL] [Abstract][Full Text] [Related]
5. Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease.
Hochberg MC; Feldman D; Stevens MB; Arnett FC; Reichlin M
J Rheumatol; 1984 Oct; 11(5):663-5. PubMed ID: 6334746
[TBL] [Abstract][Full Text] [Related]
6. [Antisynthetase syndrome].
Gran JT
Tidsskr Nor Laegeforen; 2002 Sep; 122(23):2270-2. PubMed ID: 12448266
[TBL] [Abstract][Full Text] [Related]
7. [Mechanic's hands: a characteristic cutaneous sign of antisynthetase syndrome].
Blanco S; Rodríguez E; Galache C; Cosme Alvarez-Cuesta C; Nosti D
Actas Dermosifiliogr; 2005 May; 96(4):241-4. PubMed ID: 16476375
[TBL] [Abstract][Full Text] [Related]
8. Dermatomyositis sine myositis and antisynthetase syndrome.
Climent-Albaladejo A; Saiz-Cuenca E; Rosique-Roman J; Caballero-Rodriguez J; Galvez-Munoz J
Joint Bone Spine; 2002 Jan; 69(1):72-5. PubMed ID: 11858361
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy.
Kaji K; Fujimoto M; Hasegawa M; Kondo M; Saito Y; Komura K; Matsushita T; Orito H; Hamaguchi Y; Yanaba K; Itoh M; Asano Y; Seishima M; Ogawa F; Sato S; Takehara K
Rheumatology (Oxford); 2007 Jan; 46(1):25-8. PubMed ID: 16728436
[TBL] [Abstract][Full Text] [Related]
10. [Two cases of acute progressive interstitial pneumonia associated with dermatomyositis--clinical features and immunological disorders].
Okuda Y; Takasugi K; Imai A; Oyama T; Oyama H
Ryumachi; 1993 Aug; 33(4):293-301. PubMed ID: 8235910
[TBL] [Abstract][Full Text] [Related]
11. [Extensive digital necrosis during dermatomyositis associated with MDA-5 antibodies].
Charbit L; Bursztejn AC; Mohamed S; Kaminsky P; Lerondeau B; Barbaud A; Deibener-Kaminsky J; Schmutz JL
Ann Dermatol Venereol; 2016; 143(8-9):537-42. PubMed ID: 27157503
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
Marie I; Lahaxe L; Benveniste O; Delavigne K; Adoue D; Mouthon L; Hachulla E; Constans J; Tiev K; Diot E; Levesque H; Boyer O; Jouen F
Br J Dermatol; 2010 Feb; 162(2):337-44. PubMed ID: 19845665
[TBL] [Abstract][Full Text] [Related]
13. Fatal interstitial pulmonary fibrosis in anti-Jo-1-negative amyopathic dermatomyositis.
High WA; Cohen JB; Murphy BA; Costner MI
J Am Acad Dermatol; 2003 Aug; 49(2):295-8. PubMed ID: 12894081
[TBL] [Abstract][Full Text] [Related]
14. [Analysis for the organ involvement and immnunological markers of the patients with dermatomyositis].
Li YH; Yao HH; Zhang XW; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):140-2. PubMed ID: 20396351
[TBL] [Abstract][Full Text] [Related]
15. Childhood sclerodermatomyositis with generalized morphea.
Ambade GR; Dhurat RS; Lade N; Jerajani HR
Indian J Dermatol Venereol Leprol; 2008; 74(2):148-50. PubMed ID: 18388377
[TBL] [Abstract][Full Text] [Related]
16. The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis.
de Andrade VP; De Souza FHC; Behrens Pinto GL; Shinjo SK
Adv Rheumatol; 2021 Feb; 61(1):12. PubMed ID: 33608062
[TBL] [Abstract][Full Text] [Related]
17. Sera from anti-Jo-1-positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells.
Barbasso Helmers S; Englund P; Engström M; Ahlin E; Fathi M; Janciauskiene S; Heimbürger M; Rönnelid J; Lundberg IE
Arthritis Rheum; 2009 Aug; 60(8):2524-30. PubMed ID: 19644880
[TBL] [Abstract][Full Text] [Related]
18. Juvenile amyopathic dermatomyositis.
Henning JS; Witkiewicz A; Schaffer JV; Orlow SJ
Dermatol Online J; 2005 Dec; 11(4):11. PubMed ID: 16403383
[TBL] [Abstract][Full Text] [Related]
19. Interstitial lung disease in polymyositis and dermatomyositis.
Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
[TBL] [Abstract][Full Text] [Related]
20. [The anti-Jo-1 syndrome - a specific form of myositis with interstitial lung disease].
Häussermann A; Gillissen A; Seidel W
Pneumologie; 2010 Aug; 64(8):496-503. PubMed ID: 20387195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
